Chen TW, Hsiao W, Dai MS, Lin CH, et al. Plasma cell-free tumor DNA, PIK3CA and TP53 mutations predicted inferior endocrine-based treatment outcome in endocrine receptor-positive metastatic breast cancer. Breast Cancer Res Treat 2023 Jun 21. doi: 10.1007/s10549-023-06967.
PMID: 37344660